Parker L N, Chang S, Odell W D
Clin Endocrinol (Oxf). 1978 Jan;8(1):1-5. doi: 10.1111/j.1365-2265.1978.tb01344.x.
It has been postulated, based on data in animals and the fact that the cortisol-adrenal androgen ratio is different before and after adrenarche, that prolactin (Prl) may modulate adrenal androgen secretion. As one way of testing this hypothesis, cortisol, androstenedione (A), dehydroepiandrosterone (DHA), and dehydroepiandrosterone sulphate (DHAS) were measured by radioimmunoassay in the sera of thirteen patients with suspected or proven pituitary tumours and marked chronic elevations of serum Prl (range 68-990 ng/ml, mean 198.9 ng/ml). Values for cortisol, A, DHA, and DHAS were not significantly different between the groups of normal controls and patients with elevated Prl concentrations. This is interpreted as negative evidence for the theoretical connection between Prl and adrenal androgen secretion.
基于动物实验数据以及肾上腺初现前后皮质醇与肾上腺雄激素比例不同这一事实,有人推测催乳素(Prl)可能调节肾上腺雄激素的分泌。作为检验这一假设的一种方法,通过放射免疫分析法对13例疑似或确诊垂体瘤且血清Prl显著慢性升高(范围68 - 990 ng/ml,平均198.9 ng/ml)患者的血清中的皮质醇、雄烯二酮(A)、脱氢表雄酮(DHA)和硫酸脱氢表雄酮(DHAS)进行了测量。正常对照组与Prl浓度升高的患者组之间,皮质醇、A、DHA和DHAS的值无显著差异。这被解释为Prl与肾上腺雄激素分泌之间理论联系的负面证据。